Global Insulin Pen Needles Market (By Types- Standard Insulin Pen Needle, and Safety Insulin Pen Needle. By Length- 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. By Therapy- Insulin, Growth Hormone, and Glucagon-Like-Peptide-1. By Application- Type I Diabetes, and Type II Diabetes. By End-Users- Hospitals, Home Healthcare, Clinics, OTC, and Others.) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025

March 2018 | 146 pages | ID: G94A45A1418EN
Sheer Analytics and Insights Private Limited

Abstracts

The report covers the analysis and forecast of the insulin pen needles market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn).

The study provides a detailed view of the insulin pen needles market, by segmenting it based on by types, by length, by therapy, by application, by end-users, and regional demand. Rising growth of diabetes, propels the growth of insulin pen needles market. Rise in technological advancements, is another prime factor driving the market demand. Additionally, obese people suffering from type II diabetes fuels the demand of this market.

Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by types, by length, by therapy, by application, and by end-users in all regions. These include different business strategies adopted by the leading players and their recent developments.

A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the Insulin pen needles market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the insulin pen needles market.

The report provides the size of the Insulin pen needles market in 2017 and the forecast for the next eight years up to 2025. The size of the global insulin pen needles market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been considered in estimating the growth of the global market.

Market estimates for this study have been based on revenue being derived through regional pricing trends. The Insulin pen needles market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the insulin pen needle market, split into regions. Based on types, length, therapy, applications, and end-users, the individual revenues from all the regions is summed up to achieve the global revenue for insulin pen needles. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of insulin pen needles several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.

The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Becton, Dickinson, and Company, Novo Nordisk A/S, Owen Mumford Ltd., MedExel Co., UltiMed, Inc. and few others.

The global insulin pen needles market has been segmented into:

Global Insulin Pen Needle Market: By Types

• Standard Insulin Pen Needle
• Safety Insulin Pen Needle

Global Insulin Pen Needle Market: By Length

• 4mm
• 5mm
• 6mm
• 8mm
• 10mm
• 12mm

Global Insulin Pen Needle Market: By Therapy

• Insulin
• Growth Hormone
• Glucagon-like-Peptide-1 [GLP-1]

Global Insulin Pen Needle Market: By Application

• Type I diabetes
• Type II diabetes

Global Insulin Pen Needle Market: By End-Users

• Hospitals
• Home Healthcare
• Clinics
• OTC
• Others

Global Insulin Pen Needle Market: By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• U.K.
• France
• Germany
• Italy
• Rest of Europe
• Asia Pacific
• India
• China
• Japan
• Rest of Asia Pacific
• Middle East and Africa
• South Africa
• Rest of Middle East and Africa
• Latin America
• Brazil
• Rest of Latin America

Contents

1 INTRODUCTION

1.1 MARKET SEGMENTATION

2 RESEARCH METHODOLOGY

2.1 ECOSYSTEM OF INSULIN PEN NEEDLES MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 GLOBAL INSULIN PEN NEEDLES MARKET SNAPSHOT
3.2 GLOBAL INSULIN PEN NEEDLES MARKET REVENUE, 2017– 2025(US$ MN)

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS

5 GLOBAL INSULIN PEN NEEDLES MARKET, BY TYPES

5.1 OVERVIEW
5.2 STANDARD INSULIN PEN NEEDLE
5.3 SAFETY INSULIN PEN NEEDLE

6 GLOBAL INSULIN PEN NEEDLES MARKET, BY LENGTH

6.1 OVERVIEW
6.2 4MM
6.3 5MM
6.4 6MM
6.5 8MM
6.6 10MM
6.7 12MM

7 GLOBAL INSULIN PEN NEEDLES MARKET, BY THERAPY

7.1 OVERVIEW
7.2 INSULIN
7.3 GROWTH HORMONE
7.4 GLUCAGON-LIKE-PEPTIDE-1 [GLP-1]

8 GLOBAL INSULIN PEN NEEDLES MARKET, BY APPLICATION

8.1 OVERVIEW
8.2 TYPE I DIABETES
8.3 TYPE II DIABETES

9 GLOBAL INSULIN PEN NEEDLES MARKET, BY END-USERS

9.1 HOSPITALS
9.2 HOME HEALTHCARE
9.3 CLINICS
9.4 OTC
9.5 OTHERS

10 GLOBAL INSULIN PEN NEEDLES MARKET, BY GEOGRAPHY

10.1 NORTH AMERICA
  10.1.1 MARKET DYNAMICS
    10.1.1.1 DRIVERS
    10.1.1.2 RESTRAINS
    10.1.1.3 OPPORTUNITY
  10.1.2 U.S.
  10.1.3 CANADA
  10.1.4 MEXICO
10.2 EUROPE
  10.2.1 MARKET DYNAMICS
    10.2.1.1 DRIVERS
    10.2.1.2 RESTRAINS
    10.2.1.3 OPPORTUNITY
  10.2.2 U.K.
  10.2.3 FRANCE
  10.2.4 GERMANY
  10.2.5 SPAIN
  10.2.6 REST OF EUROPE
10.3 ASIA PACIFIC
  10.3.1 MARKET DYNAMICS
    10.3.1.1 DRIVERS
    10.3.1.2 RESTRAINS
    10.3.1.3 OPPORTUNITY
  10.3.2 INDIA
  10.3.3 CHINA
  10.3.4 JAPAN
  10.3.5 REST OF ASIA PACIFIC
10.4 MIDDLE EAST AND AFRICA
  10.4.1 MARKET DYNAMICS
    10.4.1.1 DRIVERS
    10.4.1.2 RESTRAINS
    10.4.1.3 OPPORTUNITY
  10.4.2 SOUTH AFRICA
  10.4.3 REST OF MIDDLE EAST AND AFRICA
10.5 LATIN AMERICA
  10.5.1 MARKET DYNAMICS
    10.5.1.1 DRIVERS
    10.5.1.2 RESTRAINS
    10.5.1.3 OPPORTUNITY
  10.5.2 BRAZIL
  10.5.3 REST OF LATIN AMERICA

11 GLOBAL INSULIN PEN NEEDLES MARKET, BY COMPANY

11.1 INTRODUCTION
11.2 NOVO NORDISK A/S
  11.2.1 BUSINESS OVERVIEW
  11.2.2 PRODUCTS
  11.2.3 KEY STRATEGY
  11.2.4 RECENT DEVELOPMENTS
  11.2.5 SWOT ANALYSIS
11.3 OWEN MUMFORD LIMITED
  11.3.1 BUSINESS OVERVIEW
  11.3.2 PRODUCTS
  11.3.3 KEY STRATEGY
  11.3.4 RECENT DEVELOPMENTS
  11.3.5 SWOT ANALYSIS
11.4 TERUMO CORPORATION
  11.4.1 BUSINESS OVERVIEW
  11.4.2 PRODUCTS
  11.4.3 KEY STRATEGY
  11.4.4 RECENT DEVELOPMENTS
  11.4.5 SWOT ANALYSIS
11.5 MEDEXEL CO.
  11.5.1 BUSINESS OVERVIEW
  11.5.2 PRODUCTS
  11.5.3 KEY STRATEGY
  11.5.4 RECENT DEVELOPMENTS
  11.5.5 SWOT ANALYSIS
11.6 BECTON, DICKINSON, AND COMPANY
  11.6.1 BUSINESS OVERVIEW
  11.6.2 PRODUCTS
  11.6.3 KEY STRATEGY
  11.6.4 RECENT DEVELOPMENTS
  11.6.5 SWOT ANALYSIS
11.7 B BRAUN MELSUNGEN AG
  11.7.1 BUSINESS OVERVIEW
  11.7.2 PRODUCTS
  11.7.3 KEY STRATEGY
  11.7.4 RECENT DEVELOPMENTS
  11.7.5 SWOT ANALYSIS
11.8 ULTIMED INC.
  11.8.1 BUSINESS OVERVIEW
  11.8.2 PRODUCTS
  11.8.3 KEY STRATEGY
  11.8.4 RECENT DEVELOPMENTS
  11.8.5 SWOT ANALYSIS
11.9 YPSOMED HOLDING AG
  11.9.1 BUSINESS OVERVIEW
  11.9.2 PRODUCTS
  11.9.3 KEY STRATEGY
  11.9.4 RECENT DEVELOPMENTS
  11.9.5 SWOT ANALYSIS
11.10 ALLISON MEDICAL, INC.
  11.10.1 BUSINESS OVERVIEW
  11.10.2 PRODUCTS
  11.10.3 KEY STRATEGY
  11.10.4 RECENT DEVELOPMENTS
  11.10.5 SWOT ANALYSIS